[1] |
WAN Yu, YUAN Xiangfeng, GAO Wenfeng, LUO Zengxiang.
Tofacitinib in the treatment of systemic lupus erythematosus with alopecia as the first manifestation: a case report and literature review
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(9): 664-666.
|
[2] |
WANG Ting, YAO Tianhua, TAO Kang, HUANG Jinyu, LI Shifei, WANG Hongqian, WU Yazhou, ZHAI Zhifang.
Analysis of risk factors of progression from cutaneous lupus erythematosus to systemic lupus erythematosus and the establishment of predictive models
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(7): 473-478.
|
[3] |
ZHU Liyun, YANG Wenhao.
Clinical feature of pediatric bullous systemic lupus erythematosus
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(3): 151-155.
|
[4] |
MA Hongmei, LI Wenfang, SANG Subo, WANG Quanshun.
Lupus nephritis with livedo reticularis: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(10): 748-750.
|
[5] |
KONG Zelin, PI Qingyou, ZHOU Guizhi, LI Jing.
Autoimmune polyglandular syndrome type IIIC+D: a case report and literature review
[J]. China Journal of Leprosy and Skin Diseases, 2022, 38(8): 530-534.
|
[6] |
ZHOU Jie, LI Jiao, RU Lincheng, JIN Qianwei, GUO Yun.
Update of the effect of hydroxychloroquine on dyslipidemia and blood glucose in systemic Lupus Erythematosus patients
[J]. China Journal of Leprosy and Skin Diseases, 2022, 38(6): 405-408.
|
[7] |
LI Min, XIA Yumin.
Clinical characteristics of male patients with systemic lupus erythematosus
[J]. China Journal of Leprosy and Skin Diseases, 2022, 38(3): 190-194.
|
[8] |
ZENG Jun, LI Shifei, ZHOU Xiaofang, WANG Ting, SONG Zhiqiang, ZHAI Zhifang.
Correlation analysis of serum PS-PLA1 level and disease activity of systemic lupus erythematosus
[J]. China Journal of Leprosy and Skin Diseases, 2021, 37(5): 281-285.
|
[9] |
CHEN Xianxia, YU Bingqian, ZHENG Jiayuan, NIU Taoxiang, LI Yifan, LUO Zhicheng.
Bullous systemic lupus erythematosus: two cases report
[J]. China Journal of Leprosy and Skin Diseases, 2020, 36(7): 415-416.
|
[10] |
WEN Zhihua, YAO Xu.
Clinical analysis of bullous systemic lupus erythematosus
[J]. China Journal of Leprosy and Skin Diseases, 2020, 36(5): 259-261.
|
[11] |
YAO Yanru, WANG Jibo, ZHANG Ting, WEN Dawei.
Cutaneous Rosai-Dorfman-Destombes disease misdiagnosed as systemic lupus erythematosus: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2020, 36(4): 227-229.
|
[12] |
CEN Xintao, SUN Ledong.
Update of biological agents in the treatment of systemic lupus erythematosus
[J]. China Journal of Leprosy and Skin Diseases, 2019, 35(9): 572-576.
|
[13] |
ZHOU Jing, HUANG Chuang, PENG Fengling.
Efficacy of human immunoglobulin combined with prednisone in the treatment of systemic lupus erythematosus and the impact on the level of CD28, ICOS and Tim-1
[J]. China Journal of Leprosy and Skin Diseases, 2019, 35(6): 334-337.
|
[14] |
XING Yaqiong , WU Xuejingzi , SONG Jiquan.
Association between Toll like receptor 9 gene polymorphism and susceptibility to systemic lupus erythematosus in Hubei Han population
[J]. China Journal of Leprosy and Skin Diseases, 2018, 34(9): 546-549,554.
|
[15] |
XIE Shuangde, WEI Shanshan, ZHANG Huanian, WANG Guisong, PENG Xuebiao, Zhao Ke, LI Junhao, LAI Kuan.
The expression of mTORC1 pathway in murine model of systemic lupus erythematosus
[J]. China Journal of Leprosy and Skin Diseases, 2018, 34(8): 449-452.
|